{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Arteriosclerosis%2C+Coronary&page=54", "query": { "condition": "Arteriosclerosis, Coronary", "page": 54 }, "page_size": 10 }, "pagination": { "page": 54, "page_size": 10, "total_count": 2151, "total_pages": 216, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Arteriosclerosis%2C+Coronary&page=55&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Arteriosclerosis%2C+Coronary&page=53&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-17T21:04:27.049Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03507777", "title": "ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Coronary Artery Disease", "Coronary Stenosis", "Atherosclerosis", "STEMI", "STEMI - ST Elevation Myocardial Infarction", "NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI)" ], "interventions": [ { "name": "Coronary PCI guided by OCT", "type": "DEVICE" }, { "name": "Coronary PCI guided by Angiography", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Abbott Medical Devices", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2487, "start_date": "2018-05-17", "completion_date": "2023-02-28", "has_results": true, "last_update_posted_date": "2024-08-01", "last_synced_at": "2026-10-17T21:04:27.049Z", "location_count": 42, "location_summary": "Birmingham, Alabama • Scottsdale, Arizona • Burlingame, California + 37 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Burlingame", "state": "California" }, { "city": "Concord", "state": "California" }, { "city": "La Jolla", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03507777" }, { "nct_id": "NCT00326690", "title": "Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Congestive Heart Failure", "Ischemic Cardiomyopathy", "Coronary Artery Disease", "Myocardial Diseases" ], "interventions": [ { "name": "Blue Egg Device", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "BioVentrix", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2005-11", "completion_date": "2008-12", "has_results": false, "last_update_posted_date": "2023-01-26", "last_synced_at": "2026-10-17T21:04:27.049Z", "location_count": 9, "location_summary": "Los Angeles, California • St. Petersburg, Florida • Baltimore, Maryland + 5 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "St. Petersburg", "state": "Florida" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00326690" }, { "nct_id": "NCT02601560", "title": "To Evaluate Safety, Pharmacokinetics and Pharmacodynamics of MEDI6012 in Subjects With Stable Coronary Artery Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Coronary Artery Disease" ], "interventions": [ { "name": "MEDI6012", "type": "BIOLOGICAL" }, { "name": "Placebo SC", "type": "BIOLOGICAL" }, { "name": "Placebo IV", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "MedImmune LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "40 Years to 75 Years" }, "enrollment_count": 48, "start_date": "2015-12-03", "completion_date": "2016-11-03", "has_results": true, "last_update_posted_date": "2018-03-19", "last_synced_at": "2026-10-17T21:04:27.049Z", "location_count": 8, "location_summary": "Anniston, Alabama • Jacksonville, Florida • Port Orange, Florida + 5 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Port Orange", "state": "Florida" }, { "city": "Durham", "state": "North Carolina" }, { "city": "Raleigh", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02601560" }, { "nct_id": "NCT07656259", "title": "COMPARE-VENT Feasibility Pilot Study", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Respiration Failure", "Cardio Vascular Disease", "Cardiogenic Pulmonary Oedema", "Critical Illness", "Mechanical Ventilation", "Cardiogenic Shock", "Cardiopulmonary" ], "interventions": [ { "name": "Volume Controlled Mode", "type": "OTHER" }, { "name": "Pressure Controlled Mode", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 75, "start_date": "2026-07-01", "completion_date": "2027-06-30", "has_results": false, "last_update_posted_date": "2026-08-10", "last_synced_at": "2026-10-17T21:04:27.049Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT07656259" }, { "nct_id": "NCT00781118", "title": "AngelMed for Early Recognition and Treatment of STEMI", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Acute Myocardial Infarction (AMI)", "Coronary Occlusion", "Acute Coronary Syndrome" ], "interventions": [ { "name": "Guardian System", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Angel Medical Systems", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 1020, "start_date": "2008-12", "completion_date": "2017-05-17", "has_results": false, "last_update_posted_date": "2018-03-14", "last_synced_at": "2026-10-17T21:04:27.049Z", "location_count": 95, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Mesa, Arizona + 85 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00781118" }, { "nct_id": "NCT00001313", "title": "Evaluation of Patients With Known or Suspected Heart Disease", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Peripheral Artery Disease", "Coronary Disease", "Diabetes and Heart Failure", "Dilated Cardiomyopathy", "Heart Failure", "Renal Artery Stenosis", "Pulmonary Hypertension" ], "interventions": [], "intervention_types": [], "sponsor": "National Heart, Lung, and Blood Institute (NHLBI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": null, "start_date": "1992-05-10", "completion_date": "2009-01-06", "has_results": false, "last_update_posted_date": "2017-07-02", "last_synced_at": "2026-10-17T21:04:27.049Z", "location_count": 2, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" }, { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00001313" }, { "nct_id": "NCT03383224", "title": "PRISM-GENOMICS-Smoking Cessation for Patients With Coronary Artery Disease Undergoing Cardiac Catheterization or Having a Heart Attack at Barnes Hospital in St. Louis Mo", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Coronary Artery Disease", "Smoking Cessation" ], "interventions": [ { "name": "genotype-guided therapy", "type": "OTHER" }, { "name": "Nicotine patch", "type": "DRUG" }, { "name": "Smoking cessation counseling", "type": "BEHAVIORAL" } ], "intervention_types": [ "OTHER", "DRUG", "BEHAVIORAL" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2015-07-21", "completion_date": "2025-07-21", "has_results": false, "last_update_posted_date": "2021-11-01", "last_synced_at": "2026-10-17T21:04:27.049Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT03383224" }, { "nct_id": "NCT02344290", "title": "Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "HIV", "Cardiovascular Diseases" ], "interventions": [ { "name": "Pitavastatin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "40 Years to 75 Years" }, "enrollment_count": 7769, "start_date": "2015-03-26", "completion_date": "2023-08-21", "has_results": true, "last_update_posted_date": "2025-09-04", "last_synced_at": "2026-10-17T21:04:27.049Z", "location_count": 91, "location_summary": "Birmingham, Alabama • Tucson, Arizona • Los Angeles, California + 59 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02344290" }, { "nct_id": "NCT05708859", "title": "Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Type II Diabetes", "Atherosclerosis" ], "interventions": [ { "name": "Tirzepatide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Matthew J. Budoff", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "40 Years to 80 Years" }, "enrollment_count": 120, "start_date": "2024-01-02", "completion_date": "2026-05", "has_results": false, "last_update_posted_date": "2024-10-15", "last_synced_at": "2026-10-17T21:04:27.049Z", "location_count": 1, "location_summary": "Torrance, California", "locations": [ { "city": "Torrance", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05708859" }, { "nct_id": "NCT06383390", "title": "The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Atherosclerotic Cardiovascular Disease (ASCVD)", "Chronic Kidney Disease (CKD)" ], "interventions": [ { "name": "Retatrutide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": null, "sex": "ALL", "summary": "45 Years and older" }, "enrollment_count": 10000, "start_date": "2024-04-30", "completion_date": "2029-02", "has_results": false, "last_update_posted_date": "2026-10-08", "last_synced_at": "2026-10-17T21:04:27.049Z", "location_count": 204, "location_summary": "Alabaster, Alabama • Birmingham, Alabama • Daphne, Alabama + 159 more", "locations": [ { "city": "Alabaster", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Daphne", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT06383390" } ] }